LEXARIA BIOSCIENCE CORP. Current Liabilities
LEXARIA BIOSCIENCE CORP. (LEXX) had Current Liabilities of $383.41 thousand as of 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-07-13
- 2026-05-31: Liabilities, Current $383.41K.
- 2026-02-28: Liabilities, Current $214.67K.
- 2025-11-30: Liabilities, Current $1.46M.
- 2025-08-31: Liabilities, Current $1.49M.
| Period end | Liabilities, Current |
|---|---|
| 2026-05-31 | $383.41K 10-Q · filed 2026-07-13 |
| 2026-02-28 | $214.67K 10-Q · filed 2026-04-13 |
| 2025-11-30 | $1.46M 10-Q · filed 2026-01-13 |
| 2025-08-31 | $1.49M 10-Q · filed 2026-07-13 |
| 2025-05-31 | $1.49M 10-Q · filed 2025-07-14 |
| 2025-02-28 | $1.82M 10-Q · filed 2025-04-14 |
| 2024-11-30 | $297.80K 10-Q · filed 2025-01-10 |
| 2024-08-31 | $1.10M 10-K · filed 2025-11-28 |
| 2024-05-31 | $156.05K 10-Q · filed 2024-07-12 |
| 2024-02-29 | $81.72K 10-Q · filed 2024-04-09 |
| 2023-11-30 | $124.52K 10-Q · filed 2024-01-12 |
| 2023-08-31 | $267.74K 10-K · filed 2024-11-26 |
| 2023-05-31 | $1.06M 10-Q · filed 2023-07-14 |
| 2023-02-28 | $223.13K 10-Q · filed 2023-04-14 |
| 2022-11-30 | $281.52K 10-Q/A · filed 2023-01-18 |
| 2022-08-31 | $194.04K 10-K · filed 2023-11-20 |
| 2022-05-31 | $206.83K 10-Q · filed 2022-07-14 |
| 2022-02-28 | $165.54K 10-Q · filed 2022-04-11 |
| 2021-11-30 | $237.70K 10-Q · filed 2022-01-14 |
| 2021-08-31 | $153.28K 10-K · filed 2022-11-28 |
| 2021-05-31 | $221.22K 10-Q · filed 2021-07-15 |
| 2021-02-28 | $399.39K 10-Q · filed 2021-04-14 |
| 2020-11-30 | $242.47K 10-Q · filed 2021-01-14 |
| 2020-08-31 | $225.92K 10-K · filed 2021-11-29 |
| 2020-05-31 | $90.97K 10-Q · filed 2020-06-29 |
| 2020-02-29 | $63.29K 10-Q · filed 2020-04-03 |
| 2019-11-30 | $130.23K 10-Q · filed 2020-01-09 |
| 2019-08-31 | $184.51K 10-K · filed 2020-10-15 |
| 2019-05-31 | $132.29K 10-Q · filed 2019-07-08 |
| 2019-02-28 | $500.08K 10-Q · filed 2019-04-15 |
| 2018-11-30 | $129.94K 10-Q · filed 2019-01-11 |
| 2018-08-31 | $43.64K 10-K · filed 2019-11-14 |
| 2018-05-31 | $71.64K 10-Q · filed 2018-07-13 |
| 2018-02-28 | $69.04K 10-Q · filed 2018-04-12 |
| 2017-11-30 | $95.70K 10-Q · filed 2018-01-12 |
| 2017-08-31 | $92.35K 10-K · filed 2018-11-14 |
| 2017-05-31 | $40.00K 10-Q · filed 2017-07-14 |
| 2017-02-28 | $333.55K 10-Q · filed 2017-04-14 |
| 2016-11-30 | $468.55K 10-Q · filed 2017-01-13 |
| 2016-08-31 | $433.88K 10-K · filed 2017-11-27 |
| 2016-05-31 | $331.54K 10-Q · filed 2016-07-13 |
| 2016-02-29 | $284.29K 10-Q · filed 2016-04-13 |
| 2015-08-31 | $55.13K 10-K · filed 2016-11-29 |
| 2015-05-31 | $62.60K 10-Q · filed 2015-07-14 |
| 2015-02-28 | $38.15K 10-Q · filed 2015-04-14 |
| 2014-11-30 | $789.36K 10-Q · filed 2015-01-14 |
| 2014-08-31 | $918.04K 10-K · filed 2015-11-27 |
| 2014-07-31 | $957.42K 10-Q · filed 2014-11-14 |
| 2014-04-30 | $1.05M 10-Q · filed 2014-06-12 |
| 2014-01-31 | $1.47M 10-Q · filed 2014-03-12 |
| 2013-10-31 | $1.42M 10-KT · filed 2014-12-09 |
| 2013-07-31 | $1.40M 10-Q · filed 2013-09-10 |
| 2013-04-30 | $1.48M 10-Q · filed 2013-06-12 |
| 2013-01-31 | $1.55M 10-Q · filed 2013-03-13 |
| 2012-10-31 | $1.71M 10-K · filed 2014-01-24 |
| 2012-07-31 | $1.84M 10-Q · filed 2012-09-12 |
| 2012-04-30 | $1.81M 10-Q · filed 2012-06-07 |
| 2012-01-31 | $1.68M 10-Q · filed 2012-03-13 |
| 2011-10-31 | $1.08M 10-K · filed 2013-01-29 |
| 2011-07-31 | $876.74K 10-Q · filed 2011-09-14 |
| 2010-10-31 | $1.05M 10-K · filed 2012-01-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |